Response to letter to the editor by Lai-Ming Kathleen Pak et al on: Identifying predictors of SGLT2 inhibitor and GLP1R agonist use in hospital among adults with diabetes.
Saved in:
| Title: | Response to letter to the editor by Lai-Ming Kathleen Pak et al on: Identifying predictors of SGLT2 inhibitor and GLP1R agonist use in hospital among adults with diabetes. |
|---|---|
| Authors: | Colacci M; St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada; Sinai Health System, Division of General Internal Medicine, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada. Electronic address: michaelfcolacci@gmail.com., Raudanskis A; Sinai Health System, Division of General Internal Medicine, Toronto, Ontario, Canada., Fralick M; Sinai Health System, Division of General Internal Medicine, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada. |
| Source: | Journal of diabetes and its complications [J Diabetes Complications] 2025 Oct; Vol. 39 (10), pp. 109046. Date of Electronic Publication: 2025 Apr 23. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Elsevier Science Pub. Co Country of Publication: United States NLM ID: 9204583 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-460X (Electronic) Linking ISSN: 10568727 NLM ISO Abbreviation: J Diabetes Complications Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 1873-460X |
|---|---|
| DOI: | 10.1016/j.jdiacomp.2025.109046 |
